Manufactured by Parke-Davis
Uses: Tonic-clonic, Status
Common side effects: Rash, sensory disturbances
Remarks: Ineffective in controlling absences
Product Info:
The information you can obtain by clicking on the appropriate link has been provided by "AS IS" WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT.
Furthermore the information contained in this document is accurate as of its specified date and may become out of date over time and thus should be considered current only as of the date stated. This information is not intended to be a substitute for the advice of a health care professional, or a recommendation for any particular treatment plan, and is not intended to supplement, modify or supercede the information provided in the product package insert with respect to the use of the product for medical purposes.
Please note that in order to access one of the documents you will require Acrobat Reader. If you don't have this product you can download it for free from: Adobe
FURTHER READING
1. PHENYTOIN IN INFANCY AND CHILDHOOD - Albani M, In: Advances in Neurology, Vol 34, edited by A.V Delgado-Escueta et al., 1983
2. A COMPARATIVE STUDY OF THE COGNITIVE EFFECTS OF PHENYTOIN AND CARBAMAZEPINE IN NEW REFERRALS WITH EPILEPSY - D.G Andrewes et al., Epilepsia., 27:128-134, 1986
3. THE INFLUENCE OF CARBAMAZEPINE AND PHENYTOIN ON MEMORY AND OTHER ASPECTS OF COGNITIVE FUNCTION IN NEW REFERRALS WITH EPILEPSY - D.G Andrewes et al., Acta Neurol. Scand., 69:(suppl.99):23-30, 1984
4. BEHAVIOURAL EFFECTS OF PHENOBARBITONE AND PHENYTOIN IN SMALL CHILDREN - C.J Bacon et al., Arch.Dis.Childh., 56:836-840, 1981
5. PHENYTOIN WITHDRAWL AND SEIZURE FREQUENCY - E.M Bromfield et al., Neurology, 39:905-909 1989
6. INTERACTION BETWEEN VIGABATRIN AND PHENYTOIN E.H Rimmer et al., Br. J. Clin. Pharmacol. 27:27-33S 1989
7. PHARMACOKINETICS OF GABAPENTIN IN PATIENTS TREATED WITH PHENYTOIN - N.M Graves et al., Pharmacotherapy, 9:196 1989
8. PHENOBARBITAL DOES NOT ALTER PHENYTOIN STEADY-STATE SERUM CONCENTRATION OR PHARMACOKINETICS - T.R Browne et al., Neurology, 38:639-642 1988
9. HIGH-DOSE PHENYTOIN IN THE TREATMENT OF REFRACTORY EPILEPSY - J.E Cobos., Epilepsia, 28:111-114 1987
10. INTRAVENOUS PNENYTOIN IN ACUTE TREATMENT OF SEIZURES - R.E Cranford et al., Neurology, 29:1474-1479 1979
11. DISCONTINUATION OF PHENYTOIN, CARBAMAZEPINE AND VALPROATE IN PATIENTS WITH ACTIVE EPILEPSY - J.S Duncan et al., Epilepsia, 31:324-333 1990
12. DO CARBAMAZEPINE AND PHENYTOIN AGGRAVATE JUVENILE MYOCLONIC EPILEPSY? - P. Genton et al., Neurology 2000 55: 1106-1109
13. COGNITIVE IMPAIRMENT IN NEW CASES OF EPILEPSY RANDOMLY ASSIGNED TO CARBAMAZEPINE, PHENYTOIN AND SODIUM VALPROATE - I. Forsythe et al., Dev. Med. Child Neurol., 33:524-536 1991
14. A COMPARISON OF PHENYTOIN AND PHENETURIDE IN PATIENTS WITH EPILEPSY: a DOUBLE-BLIND CROSS-OVER TRIAL - F.B Gibberd et al., J. Neurol. Neurosurg. Psychiatry, 45:1113-1118 1982
15. CLINICAL SIDE EFFECTS OF PHENOBARBITAL, PRIMIDONE, PHENYTOIN, CARBAMAZEPINE, AND VALPROATE DURING MONOTHERAPY IN CHILDREN - J.L Herrnaz et al., Epilepsia, 29:794-804 1988
16. BIO-AVAILABILTY AND DISSOLUTION OF THREE PHENYTOIN PREPARATIONS FOR CHILDREN - S. Hodge et al., Dev. Med. Child Neurol., 28:708-712 1986
17. CARBAMAZEPINE VS PHENYTOIN: A CONTROLLED CLINICAL TRIAL IN FOCAL MOTOR AND GENERALIZED EPILEPSY - M. Kosteljanetz et al., Arch. Neurol., 36:22-24 1979
18. TREATMENT OF ACUTE SEIZURES AND STATUS EPILEPTICUS WITH INTRAVENOUS PHENYTOIN - I.E Leppick et al., In: Advances in Neurology. Vol.34, Status Epilepticus., 447-451 1983
19. PHENYTOIN-INDUCED SEIZURES: A PARADOXICAL EFFECT OF TOXIC CONCENTRATIONS IN EPILEPTIC PATIENTS - I. Osorio et al., Epilepsia., 30:230-234 1989
© 2001-2007 Epiweb.org